Showing 917 results
-
Story /NIBR investigator develops technology that uses tumor DNA in the blood for diagnostics
-
Story /Lutz Hegemann shares how lessons learned treating patients with leprosy influenced the way he thinks about the pharmaceutical business.
-
Story /Canavan describes how flexible working positively impacts his team.
-
Story /Novartis taps MOOC technology to share chemistry education with the world
-
Press release /The EC approval is based on the first global CAR-T registration trials, which included patients from eight European countries and demonstrated durable responses and a consistent safety profile in…
-
Press release /Scemblix provides much-needed and long-awaited new option for patients with chronic myeloid leukemia (CML) who suffer with intolerance or inadequate response after at least two previous…
-
Press release /Data from the MONALEESA Phase III program provide further evidence of the unique profile of Kisqali, the CDK4/6 inhibitor with the longest reported median overall survival (OS) in HR+/HER2-…
-
Story /When Carl was diagnosed with metastatic prostate cancer, he and his wife Arlene began navigating his cancer journey while still looking to enjoy their retirement – hoping to remain active with family and friends in their retirement community.
-
Story /Meet our Vice President of Strategic Data and Digital at Novartis Oncology.